Protective measures for COVID-19 for healthcare providers and laboratory personnel

In the COVID-19 pandemic, which affects the whole world, healthcare professionals HCP are at high risk of transmission due to their direct contact with patients with COVID-19. Therefore, how to ensure the triage of the patient with acute respiratory symptoms should be determined in advance, the contact distance should be arranged to be at least 2 m, COVID-19 suspect or diagnosed patient should be instructed to wear a surgical mask. During the care of these patients, HCP should wear their personal protective equipment PPE in accordance with the procedure and should not neglect hand hygiene. The samples of the patient with known or suspected COVID-19, patient should also be known to be risky in terms of contamination, and a risk assessment should be performed for the procedures to be performed in laboratories. The PPE should be used in accordance with the procedure to be performed. The protection of the HCP, who sacrifice at the risk of life, is possible only by complying with infection control and precautions.

Keywords:

COVID-19 healthcare providers, personal protection equipment,

PDF

___

1. European Centre for Disease Prevention and Control. Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK–sixth update. Stockholm, Sweden: ECDC; 2020.
2. Public Health England. Guidance.Transmission characteristics and principles of infection prevention and control. Updated 3 April 2020. London, UK: PHE; 2020.
3. Doremalen NV, Bushmaker T, Morris DH, Holbrook MG, Gamble A et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. New England Journal of Medicine 2020; 382: 1564-1567. doi: 10.1056/ NEJMc2004973
4. Zhang Z, Liu S, Xiang M, Li S, Zhao D et al. Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions. Frontiers of Medicine 2020. doi:101007/ s11684-020-0765-x
5. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China. JAMA 2020; 323 (11): 1061-1069. doi: 101001/jama20201585
6. Centers for Diseases Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings. Atlanta, Georgia, USA: CDC; 2020.
7. European Centre for Disease Prevention and Control. Infection prevention and control for COVID-19 in healthcare settings 12 March 2020. ECDC Technical Report. Stockholm, Sweden: ECDC; 2020.
8. Novel Coronavirus 2019 (COVID-19). Nationa linterim guidelines for public health management of contacts of cases of COVID-19; 2020.
9. Tan SS, Yan B, Saw S, Lee CK, Chong AT et al. Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore. Journal of Clinical Pathology 2020: 01-4. doi: 101136/jclinpath-2020-206563
10. World Health Organization. Infection prevention and control during health care when COVID-19 is suspected: interim guidance 19 March 2020. Geneva, Switzerland: WHO; 2020.
11. Malhotra N, Gupta N, Ish S, Ish P. COVID-19 in intensive care. Some necessary steps for health care workers. Archives for Chest Diseases 2020; 90 (1): 20201284. doi: 10.4081/ monaldi.2020.1284
12. Tran K, Cimon K, Severn M, Carmem L. Pessoa-Silva CL et al. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7(4): e35797 doi: 10.1371/journal.pone.0035797
.13. Ferioli M, Cisternino C, Leo V, Pisani L, Palange P et al. Protecting healthcare workers from SARS-CoV-2 infection: practical indications. European Respiratory Review 2020; 29: 200068 doi: 101183/160006170068-2020
14. Public Health England. Guidance. Reducing the risk of transmission of COVID-19 in the hospital setting Updated 7 April 2020. London, UK: PHE; 2020.
15. Centers for Diseases Control and Prevention. Interim U.S. guidance for risk assessment and public health management of healthcare personnel with potential exposure in a healthcare setting to patients with Coronavirus Disease (COVID-19). Atlanta, Georgia, USA: CDC; 2020.
16. Republic of Turkey Ministry of Health. Public health general directorate. COVID-19 (SARS-CoV-2) infection guideline. COVID-19 medical advisory committee study. Ankara, Turkey: Republic of Turkey Ministry of Health; 2020.
17. Liang T. Handbook of COVID-19 Prevention and Treatment. Hangzhou, China: Zhejiang University School of Medicine; 2020.
18. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals. Ocular Immunology and Inflammation 2020; 28 (3): 391-395. doi: 101080/0927394820201738501
19. Health Protection Scotland. UK Coronavirus COVID-19 response. Infection prevention and control measures. Scotland: HPS; 2020.
20. Public Health England. Guidance COVID-19 personal protective equipment (PPE) Updated 7 April 2020. London, UK: PHE; 2020.
21. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance 13 March 2020. Geneva, Switzerland: WHO; 2020.
22. ENTUK. Guidelines for changes in ENT during COVID-19 Pandemic. London: ENTUK; 2020.
23. Centers for Diseases Control and Prevention. Coronavirus Disease 2019 (COVID-19). Strategies for optimizing the supply of n95 respirators. Atlanta, Georgia, USA: CDC; 2020.
24. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Scientific brief. Geneva, Switzerland: WHO; 2020.
25. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (sars-cov-2) from a symptomatic patient. JAMA 2020. doi:101001/jama20203227
26. Queensland Health. Interim infection prevention and control guidelines for the management of COVID-19 in healthcare settings. Version 1.10: 27 March 2020. Brisbane, Australia: Queensland Health; 2020.
27. Wua YC, Chena CS, Chan YJ. The outbreak of COVID-19: An overview. Journal of Chinese Medical Association; 83 (3): 217- 220. doi: 101097/JCMA0000000000000270
28. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019- nCoV) infection is suspected: interim guidance 13 March 2020. Geneva, Switzerland: WHO; 2020.
29. World Health Organization. Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) Interim guidance 12 February 2020. Geneva, Switzerland: WHO; 2020.
30. World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases interim guidance 19 March 2020. Geneva, Switzerland: WHO; 2020.
31. Health Protection Scotland. COVID-19 Guidance for sampling and laboratory investigations Version 7.2. Scotland: HPS; 2020 32. COVID-19: protecting health-care workers. Lancet 2020; 395: 922.

Turkish Journal of Medical Sciences-Cover

ISSN: 1300-0144
Yayın Aralığı: Yılda 6 Sayı
Yayıncı: TÜBİTAK

Arşiv